Photodynamic Therapy does not Prevent Cutaneous Squamous-Cell Carcinoma in Organ-Transplant Recipients: Results of a Randomized-Controlled Trial
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (3) , 569-574
- https://doi.org/10.1038/sj.jid.5700098
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The present and future role of photodynamic therapy in cancer treatmentThe Lancet Oncology, 2004
- A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipientsBritish Journal of Dermatology, 2004
- Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipientsTransplantation, 2004
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and managementJournal of the American Academy of Dermatology, 2002
- Photodynamic therapy with violet light and topical δ‐aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinomaJournal of the European Academy of Dermatology and Venereology, 2001
- Photodynamic therapy: a clinical reality in the treatment of cancerThe Lancet Oncology, 2000
- Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.Journal of Clinical Oncology, 1995
- Sunlight, keratotic skin lesions and skin cancer in renal transplant recipientsBritish Journal of Dermatology, 1993
- INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDSTransplantation, 1990